Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients - Wikidata - wikimedia - TriplyDB

Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients

Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients

http://www.wikidata.org/entity/Q36993253

about

Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus Type I interferon blockade in systemic lupus erythematosus: where do we stand?Emerging therapies for systemic lupus erythematosus--focus on targeting interferon-alpha Interferon-alpha: a therapeutic target in systemic lupus erythematosus Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus.Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases.Association of IRF5 polymorphisms with activation of the interferon alpha pathway The type I interferon system in the etiopathogenesis of autoimmune diseases.Adipokine gene expression in peripheral blood of adult and juvenile dermatomyositis patients and their relation to clinical parameters and disease activity measures Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity Cytokine disturbances in systemic lupus erythematosus.Serum level of eight cytokines in Han Chinese patients with systemic lupus erythematosus using multiplex fluorescent microsphere method.Association of large intergenic noncoding RNA expression with disease activity and organ damage in systemic lupus erythematosus.Biologic predictors of clinical improvement in rituximab-treated refractory myositis Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus Tolerogenic versus inflammatory activity of peripheral blood monocytes and dendritic cells subpopulations in systemic lupus erythematosus.Validation of new biomarkers in systemic autoimmune diseases Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.Potential role of IFNα in adult lupus.Biomarkers for lupus nephritis: a critical appraisal.Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances.Current advances in lupus genetic and genomic studies in Asia.The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis.Urine biomarkers in juvenile-onset SLE nephritis.Role of TWEAK in lupus nephritis: a bench-to-bedside review.The role of cytokines in the pathogenesis of systemic lupus erythematosus - from bench to bedside.Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine.Type I Interferon Inhibition of MicroRNA-146a Maturation Through Up-Regulation of Monocyte Chemotactic Protein-Induced Protein 1 in Systemic Lupus Erythematosus.Mass cytometry identifies a distinct monocyte cytokine signature shared by clinically heterogeneous pediatric SLE patients.The Friend leukaemia virus integration 1 (Fli-1) transcription factor affects lupus nephritis development by regulating inflammatory cell infiltration into the kidney.Atorvastatin therapy reduces interferon-regulated chemokine CXCL9 plasma levels in patients with systemic lupus erythematosus.Interferon-induced versus chemokine transcripts as lupus biomarkers.Cytokines in relation to autoantibodies before onset of symptoms for systemic lupus erythematosus.Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus.Heterogeneity of the Type I Interferon Signature in Rheumatoid Arthritis: A Potential Limitation for Its Use As a Clinical Biomarker.Longitudinal association of type 1 interferon-induced chemokines with disease activity in systemic lupus erythematosus.Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.Novel biomarkers for systemic lupus erythematosus.

P2860

Q26782454-34D7F2E8-57DF-4E3A-A603-854920BFCFBA Q26865441-1F738DFB-A2FD-4F45-868E-93C9C5C16FE6 Q28265144-D52A1607-A562-439D-9788-794A9689ED6D Q33744320-EDB642BE-C05C-444C-A5AB-43603F0483F9 Q33829507-DB6487F5-CA79-401D-AB33-A1D693795FDD Q34115767-54532143-FECB-4385-8511-A054700A5714 Q34240254-6C6CFA63-7C00-408F-A4C9-71605BBB9E25 Q34779998-A49E0CF5-CA33-425C-988B-2FE31F166FC3 Q35102479-8E09788D-BF4F-4036-9B4B-0907427C93D6 Q35514368-DCE54170-A68C-4FF6-BE96-7976D8B15140 Q35540694-30E6FC03-5F8C-4EC3-98C4-54F78D51A3D0 Q35557898-2162C1C7-64E8-423A-BDCC-135B45A0B1A7 Q35617573-92E289C4-568B-4F29-958B-AE675A6FCC87 Q35631856-DBDDC7EA-B8B6-45B9-9CAE-1668A4F2DAA8 Q35633012-DF198DA5-D256-47DB-85E3-0C11E6994337 Q35779841-96630AED-A5B0-45B3-9FF3-7F601EE5A5B4 Q35825371-F1F12EC2-8AD5-42AE-B08D-199C43D83C79 Q36219637-66963735-BCD9-422C-B3ED-87839A1EC474 Q36231859-ACE7B8B9-7D8A-42EC-91AC-D347AFFBF6B8 Q37453911-EAAE8A6D-8CF9-4169-8C29-937DD827C521 Q37730992-1996EF60-B9AB-4466-9D0F-512B27BD115A Q37736277-FBF27871-9D80-4842-9AD9-9EE40AD9BBB1 Q37751877-B5F8231F-F6B8-4ECA-A75A-085C53F4C7CD Q37800293-85BB5E7D-E9D1-4F8E-B0D0-7BB7421EF639 Q37849465-6D42367B-76D2-4DAA-8AA0-F1F57FFEC8E1 Q38010347-52758045-4FB8-48FC-B527-50C076CC81C6 Q38021183-3E6BDCD1-CC8F-4B3B-ABAF-1873C90D393D Q38085723-25554A63-3A6B-43ED-9A83-5C6499EE2CDA Q38335622-F9B6B12C-1BD1-4269-B19B-AD2C8C52535D Q38840206-6308A664-7B84-4831-8699-02811FCB16CD Q40260152-8CADF7F0-5D78-464D-9839-94E79102EDEE Q42234669-8EEB0CD0-DA16-473B-BA3C-EC6EE4FD63E6 Q43089915-E4C30A3A-7BD3-474D-B5B4-F25175089F17 Q43162143-7108CE96-0D14-4817-8A16-602078F6F1BA Q47221390-E49BF530-E0BC-4A79-9D2A-71799A913510 Q47267579-18E5CE87-6C58-4C3F-8367-D87B04272A94 Q49539654-BF88212A-9F25-4DC4-ABB6-04640E84A627 Q49830970-D9545A72-52E5-414D-AE0F-27BB4414E88C Q51030902-097F7844-51DB-4D3F-99F9-581CD69B959D Q52552445-AF3A76D4-E46D-4853-8620-4F4409E94F7B

P2860

Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients

http://www.wikidata.org/entity/Q36993253

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Association of elevated transc ...... c lupus erythematosus patients

@en

type

label

Association of elevated transc ...... c lupus erythematosus patients

@en

prefLabel

Association of elevated transc ...... c lupus erythematosus patients

@en

P1433

Q36993253-69BDDCE0-BECE-4D7B-A85F-5247117651C7

P1476

Q36993253-9FF809E0-8514-4F61-88FE-150A9EF4F776

P2093

Q36993253-01B8548C-D286-4614-84F4-6B248EAC1A60

Q36993253-34A5539E-1469-4BF0-A214-6F8B2DE5D234

Q36993253-67807204-B502-4148-A5C1-96BDAACBF142

Q36993253-71A7F156-E2A7-492E-974F-85671B6E4D90

Q36993253-ADC8CFBD-D19A-448E-862A-B97E84022ADA

Q36993253-ADCE6648-C84B-468E-B3F8-67CBA047F0DF

Q36993253-F27D6280-0727-4F9E-A38B-64CC8AAE48D7

P2860

Q36993253-021AF598-0A90-48FA-A187-D192F43ED8B5

Q36993253-03EA78FE-5CA4-4C43-A9A9-96C0BD9BDD8E

Q36993253-52E1B7BC-E25B-4ABC-A434-AE122E5615AC

Q36993253-59CCB35C-E625-4908-8646-15743355EE6E

Q36993253-59D634D8-2D8B-4714-918D-401EFB877AC5

Q36993253-60622D87-0800-4A86-8DB6-60071C81F386

Q36993253-6851BF09-3B50-4911-B634-9FB484E20AB7

Q36993253-71D43DFB-CF9C-4915-A84A-18EB70FE031D

Q36993253-75A6AFEB-05E5-4033-997A-492ABC8F5032

Q36993253-94FD9725-6956-4B6B-ABCC-9B4634814F61

P2888

Q36993253-20DC528C-2FE2-43F5-B9E6-1B1054FF66C0

P304

Q36993253-3C27E37F-6124-4D8B-A177-B07449B2DCD5

P31

Q36993253-3A5461C3-2ED1-4A32-8415-4C93E4024AA6

P356

Q36993253-9C574B90-592A-4AFA-9615-49AA89C82328

P433

Q36993253-29E5BAA3-3D67-492C-A6EC-96C6EE174320

P478

Q36993253-CF2BE15E-437D-4395-BD61-7DA4F280698A

P577

Q36993253-24A31803-3954-48D4-806F-FAF2F0B488C6

P5875

Q36993253-919EC8D9-1C54-4931-9C5F-AE1AF62F6804

P6179

Q36993253-5BE938E2-3646-4B28-86FA-D5D47F5B058A

P698

Q36993253-3C521F7B-4AED-4C31-B4B3-D06B3D548C69

P932

Q36993253-EF20CB6A-4971-457E-B129-2B941F1E7160

P356

P1433

Arthritis Research and Therapy

P1476

Association of elevated transc ...... c lupus erythematosus patients

@en

P2093

Chunde Bao

http://www.w3.org/2001/XMLSchema#string

Huijuan Cui

http://www.w3.org/2001/XMLSchema#string

Jing Chen

http://www.w3.org/2001/XMLSchema#string

Nan Shen

http://www.w3.org/2001/XMLSchema#string

Qiong Fu

http://www.w3.org/2001/XMLSchema#string

Xiaoqing Chen

http://www.w3.org/2001/XMLSchema#string

Yanzhi Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Genomic organization, sequence and transcriptional regulation of the human CXCL 11(1) gene

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus

The 1982 revised criteria for the classification of systemic lupus erythematosus

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

The biology of chemokines and their receptors

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus

Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis.

P2888

P304

R112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR2510

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23257784

http://www.w3.org/2001/XMLSchema#string

P6179

1030114763

http://www.w3.org/2001/XMLSchema#string

P698

18793417

http://www.w3.org/2001/XMLSchema#string

P932

2592795

http://www.w3.org/2001/XMLSchema#string